PUB - Publikationen an der Universität Bielefeld

Plasma hemostatic factors and endothelial markers in four racial/ethnic groups: the MESA study.
Lutsey PL, Cushman M, Steffen LM, Green D, Barr RG, Herrington D, Ouyang P, Folsom AR., J. Thromb. Haemost. 4(12), 2006
PMID: 17002663

Effect of plasminogen activator inhibitor-1 deficiency on nutritionally-induced obesity in mice.
Lijnen HR., Thromb. Haemost. 93(5), 2005
PMID: 15886793

AUTHOR UNKNOWN, 2007

Plasminogen activator inhibitor-1: a common denominator in obesity, diabetes and cardiovascular disease.
De Taeye B, Smith LH, Vaughan DE., Curr Opin Pharmacol 5(2), 2005
PMID: 15780823

Food intake patterns associated with incident type 2 diabetes: the Insulin Resistance Atherosclerosis Study.
Liese AD, Weis KE, Schulz M, Tooze JA., Diabetes Care 32(2), 2008
PMID: 19033409

The genetics of haemostasis: a twin study.
de Lange M, Snieder H, Ariens RA, Spector TD, Grant PJ., Lancet 357(9250), 2001
PMID: 11197396

Body adiposity index versus body mass index and other anthropometric traits as correlates of cardiometabolic risk factors.
Lichtash CT, Cui J, Guo X, Chen YD, Hsueh WA, Rotter JI, Goodarzi MO., PLoS ONE 8(6), 2013
PMID: 23776578

Synthesis and secretion of plasminogen activator inhibitor-1 by human preadipocytes.
Crandall DL, Quinet EM, Morgan GA, Busler DE, McHendry-Rinde B, Kral JG., J. Clin. Endocrinol. Metab. 84(9), 1999
PMID: 10487691

Dietary fat intake and polymorphisms at the PPARG locus modulate BMI and type 2 diabetes risk in the D.E.S.I.R. prospective study.
Lamri A, Abi Khalil C, Jaziri R, Velho G, Lantieri O, Vol S, Froguel P, Balkau B, Marre M, Fumeron F., Int J Obes (Lond) 36(2), 2011
PMID: 21540831

Determinants of plasma levels of plasminogen activator inhibitor-1 : A study of normotensive twins.
Cesari M, Sartori MT, Patrassi GM, Vettore S, Rossi GP., Arterioscler. Thromb. Vasc. Biol. 19(2), 1999
PMID: 9974413

The natural PPAR agonist linoleic acid stimulated insulin release in the rat pancreas.
Lai MC, Teng TH, Yang C., J. Vet. Med. Sci. 75(11), 2013
PMID: 23832628

Plasminogen activator inhibitor-1 (PAI-1): a key factor linking fibrinolysis and age-related subclinical and clinical conditions.
Cesari M, Pahor M, Incalzi RA., Cardiovasc Ther 28(5), 2010
PMID: 20626406

Plasminogen activator and plasminogen activator inhibitor activities in a reference population.
Krishnamurti C, Tang DB, Barr CF, Alving BM., Am. J. Clin. Pathol. 89(6), 1988
PMID: 3259399

Genetic determination of acute phase reactant levels: the strong heart study.
Best LG, North KE, Tracy RP, Lee ET, Howard BV, Palmieri V, Maccluer JW., Hum. Hered. 58(2), 2004
PMID: 15711091

Association of dietary patterns with serum adipokines among Japanese: a cross-sectional study.
Kashino I, Nanri A, Kurotani K, Akter S, Yasuda K, Sato M, Hayabuchi H, Mizoue T., Nutr J 14(), 2015
PMID: 26058488

Metformin prevents endotoxin-induced liver injury after partial hepatectomy.
Bergheim I, Luyendyk JP, Steele C, Russell GK, Guo L, Roth RA, Arteel GE., J. Pharmacol. Exp. Ther. 316(3), 2005
PMID: 16322356

Role of tumor necrosis factor α (TNFα) in the onset of fructose-induced nonalcoholic fatty liver disease in mice.
Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I., J. Nutr. Biochem. 22(6), 2010
PMID: 20801629

Metformin prevents alcohol-induced liver injury in the mouse: Critical role of plasminogen activator inhibitor-1.
Bergheim I, Guo L, Davis MA, Lambert JC, Beier JI, Duveau I, Luyendyk JP, Roth RA, Arteel GE., Gastroenterology 130(7), 2006
PMID: 16762632

AUTHOR UNKNOWN, 0

Fructose-induced steatosis in mice: role of plasminogen activator inhibitor-1, microsomal triglyceride transfer protein and NKT cells.
Kanuri G, Spruss A, Wagnerberger S, Bischoff SC, Bergheim I., Lab. Invest. 91(6), 2011
PMID: 21423135

Critical role of plasminogen activator inhibitor-1 in cholestatic liver injury and fibrosis.
Bergheim I, Guo L, Davis MA, Duveau I, Arteel GE., J. Pharmacol. Exp. Ther. 316(2), 2005
PMID: 16221737

Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease.
Kanuri G, Ladurner R, Skibovskaya J, Spruss A, Konigsrainer A, Bischoff SC, Bergheim I., Liver Int. 35(2), 2014
PMID: 24351080

Fat cell size and adipokine expression in relation to gender, depot, and metabolic risk factors in morbidly obese adolescents.
Zhang Y, Zitsman JL, Hou J, Fennoy I, Guo K, Feinberg J, Leibel RL., Obesity (Silver Spring) 22(3), 2013
PMID: 23804589

Energy-restricted high-fat diets only partially improve markers of systemic and adipose tissue inflammation.
Kalupahana NS, Voy BH, Saxton AM, Moustaid-Moussa N., Obesity (Silver Spring) 19(2), 2010
PMID: 20847734

Effects of a high-fat diet on spontaneous metastasis of Lewis lung carcinoma in plasminogen activator inhibitor-1 deficient and wild-type mice.
Yan L, DeMars LC., PLoS ONE 9(10), 2014
PMID: 25356654

AUTHOR UNKNOWN, 0

The contribution of different adipose tissue depots to plasma plasminogen activator inhibitor-1 (PAI-1) levels.
Barnard SA, Pieters M, De Lange Z., Blood Rev. 30(6), 2016
PMID: 27233154

Isocaloric intake of a high-fat diet promotes insulin resistance and inflammation in Wistar rats.
Jacob PS, de Meneses Fujii TM, Yamada M, Borges MC, Pantaleao LC, Borelli P, Fock R, Rogero MM., Cell Biochem. Funct. 31(3), 2012
PMID: 23008133

Central obesity, the metabolic syndrome, and plasminogen activator inhibitor-1 in young adults.
Appel SJ, Harrell JS, Davenport ML., J Am Acad Nurse Pract 17(12), 2005
PMID: 16293162

A short-term diet and exercise intervention ameliorates inflammation and markers of metabolic health in overweight/obese children.
Izadpanah A, Barnard RJ, Almeda AJ, Baldwin GC, Bridges SA, Shellman ER, Burant CF, Roberts CK., Am. J. Physiol. Endocrinol. Metab. 303(4), 2012
PMID: 22713506

Effects of increased wholegrain consumption on immune and inflammatory markers in healthy low habitual wholegrain consumers.
Ampatzoglou A, Williams CL, Atwal KK, Maidens CM, Ross AB, Thielecke F, Jonnalagadda SS, Kennedy OB, Yaqoob P., Eur J Nutr 55(1), 2015
PMID: 25618418

The Biochemistry, Physiology and Pathological roles of PAI-1 and the requirements for PAI-1 inhibition in vivo.
Van De Craen B, Declerck PJ, Gils A., Thromb. Res. 130(4), 2012
PMID: 22801256

PAI-1, progress in understanding the clinical problem and its aetiology.
Iwaki T, Urano T, Umemura K., Br. J. Haematol. 157(3), 2012
PMID: 22360729

Energy intake is associated with endotoxemia in apparently healthy men.
Amar J, Burcelin R, Ruidavets JB, Cani PD, Fauvel J, Alessi MC, Chamontin B, Ferrieres J., Am. J. Clin. Nutr. 87(5), 2008
PMID: 18469242

Metformin protects against the development of fructose-induced steatosis in mice: role of the intestinal barrier function.
Spruss A, Kanuri G, Stahl C, Bischoff SC, Bergheim I., Lab. Invest. 92(7), 2012
PMID: 22525431

Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.
Huang J, Sabater-Lleal M, Asselbergs FW, Tregouet D, Shin SY, Ding J, Baumert J, Oudot-Mellakh T, Folkersen L, Johnson AD, Smith NL, Williams SM, Ikram MA, Kleber ME, Becker DM, Truong V, Mychaleckyj JC, Tang W, Yang Q, Sennblad B, Moore JH, Williams FM, Dehghan A, Silbernagel G, Schrijvers EM, Smith S, Karakas M, Tofler GH, Silveira A, Navis GJ, Lohman K, Chen MH, Peters A, Goel A, Hopewell JC, Chambers JC, Saleheen D, Lundmark P, Psaty BM, Strawbridge RJ, Boehm BO, Carter AM, Meisinger C, Peden JF, Bis JC, McKnight B, Ohrvik J, Taylor K, Franzosi MG, Seedorf U, Collins R, Franco-Cereceda A, Syvanen AC, Goodall AH, Yanek LR, Cushman M, Muller-Nurasyid M, Folsom AR, Basu S, Matijevic N, van Gilst WH, Kooner JS, Hofman A, Danesh J, Clarke R, Meigs JB; DIAGRAM Consortium, Kathiresan S, Reilly MP; CARDIoGRAM Consortium, Klopp N, Harris TB, Winkelmann BR, Grant PJ, Hillege HL, Watkins H; C4D Consortium, Spector TD, Becker LC, Tracy RP, Marz W, Uitterlinden AG, Eriksson P, Cambien F; CARDIOGENICS Consortium, Morange PE, Koenig W, Soranzo N, van der Harst P, Liu Y, O'Donnell CJ, Hamsten A, Attwood T, Belz S, Braund P, Brocheton J, Cambien F, Cooper J, Diemert P, Deloukas P, Eardman J, Foad N, Godefroy T, Goodall AH, Gracey J, Gray E, Gwilliams R, Heimerl S, Hengstenberg C, Jolley J, Krishnan U, Lloyd-Jones H, Liljedahl U, Lugauer I, Lundmark P, Moore JS, Montalescot G, Muir D, Murray E, Nelson CP, Neudert J, Niblett D, O'Leary K, Ouwehand WH, Pollard H, Proust C, Rankin A, Rendon A, Rice CM, Sager HB, Samani NJ, Sambrook J, Schmitz G, Scholz M, Schroeder L, Schunkert H, Stephens J, Syvannen AC, Tennstedt S, Wallace C, Crisp-Hihn A, Maouche S., Blood 120(24), 2012
PMID: 22990020

Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease.
Alessi MC, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I., Diabetes 46(5), 1997
PMID: 9133556

A comparative study of hexokinase from yeast and animal tissues.
SLEIN MW, CORI GT, CORI CF., J. Biol. Chem. 186(2), 1950
PMID: 14794672

Plasminogen activator inhibitor 1, transforming growth factor-beta1, and BMI are closely associated in human adipose tissue during morbid obesity.
Alessi MC, Bastelica D, Morange P, Berthet B, Leduc I, Verdier M, Geel O, Juhan-Vague I., Diabetes 49(8), 2000
PMID: 10923640

Moderate genetic influences on plasma levels of plasminogen activator inhibitor-1 and evidence of genetic and environmental influences shared by plasminogen activator inhibitor-1, triglycerides, and body mass index.
Hong Y, Pedersen NL, Egberg N, de Faire U., Arterioscler. Thromb. Vasc. Biol. 17(11), 1997
PMID: 9409255

Urokinase-type plasminogen activator increases hepatocyte growth factor activity required for skeletal muscle regeneration.
Sisson TH, Nguyen MH, Yu B, Novak ML, Simon RH, Koh TJ., Blood 114(24), 2009
PMID: 19812386

Plasma PAI-1 levels are more strongly related to liver steatosis than to adipose tissue accumulation.
Alessi MC, Bastelica D, Mavri A, Morange P, Berthet B, Grino M, Juhan-Vague I., Arterioscler. Thromb. Vasc. Biol. 23(7), 2003
PMID: 12750120

The influence of high fat diet on the fibrinolytic activity.
Ho CH, Chwang LC, Hwang BH., Thromb. Res. 77(3), 1995
PMID: 7740512

High-Saturated-Fat Diet Increases Circulating Angiotensin-Converting Enzyme, Which Is Enhanced by the rs4343 Polymorphism Defining Persons at Risk of Nutrient-Dependent Increases of Blood Pressure.
Schuler R, Osterhoff MA, Frahnow T, Seltmann AC, Busjahn A, Kabisch S, Xu L, Mosig AS, Spranger J, Mohlig M, Hornemann S, Kruse M, Pfeiffer AF., J Am Heart Assoc 6(1), 2017
PMID: 28096099

PAI-1 and the metabolic syndrome: links, causes, and consequences.
Alessi MC, Juhan-Vague I., Arterioscler. Thromb. Vasc. Biol. 26(10), 2006
PMID: 16931789

Metabolic determinants are much more important than genetic polymorphisms in determining the PAI-1 activity and antigen plasma concentrations: a family study with part of the Stanislas Cohort.
Henry M, Tregouet DA, Alessi MC, Aillaud MF, Visvikis S, Siest G, Tiret L, Juhan-Vague I., Arterioscler. Thromb. Vasc. Biol. 18(1), 1998
PMID: 9445260

Expression profiling identifies genes that continue to respond to insulin in adipocytes made insulin-resistant by treatment with tumor necrosis factor-alpha.
Sartipy P, Loskutoff DJ., J. Biol. Chem. 278(52), 2003
PMID: 14530283

Differences in plasminogen activator inhibitor 1 in subcutaneous versus omental adipose tissue in non-obese and obese subjects.
He G, Pedersen SB, Bruun JM, Lihn AS, Jensen PF, Richelsen B., Horm. Metab. Res. 35(3), 2003
PMID: 12734779

Effects of metabolic risk factors on production of plasminogen activator inhibitor-1 and adiponectin by adipocytes.
Sakamoto K, Sakamoto T, Ogawa H., Circ. J. 72(5), 2008
PMID: 18441469

Acute effects of fatty acids on insulin secretion from rat and human islets of Langerhans.
Gravena C, Mathias PC, Ashcroft SJ., J. Endocrinol. 173(1), 2002
PMID: 11927386

A novel plasminogen activator inhibitor-1 inhibitor, TM5441, protects against high-fat diet-induced obesity and adipocyte injury in mice.
Piao L, Jung I, Huh JY, Miyata T, Ha H., Br. J. Pharmacol. 173(17), 2016
PMID: 27339909

Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironment.
Gramling MW, Church FC., Thromb. Res. 125(5), 2010
PMID: 20079523

Genetic and environmental influences on the fibrinolytic system: a twin study.
Peetz D, Victor A, Adams P, Erbes H, Hafner G, Lackner KJ, Hoehler T., Thromb. Haemost. 92(2), 2004
PMID: 15269831

Effects of a short-term intervention with a paleolithic diet in healthy volunteers.
Osterdahl M, Kocturk T, Koochek A, Wandell PE., Eur J Clin Nutr 62(5), 2007
PMID: 17522610

Increased food intake and energy expenditure following administration of olanzapine to healthy men.
Fountaine RJ, Taylor AE, Mancuso JP, Greenway FL, Byerley LO, Smith SR, Most MM, Fryburg DA., Obesity (Silver Spring) 18(8), 2010
PMID: 20134408

The Role of Plasminogen Activator Inhibitor Type-1 in Fibrosis.
Flevaris P, Vaughan D., Semin. Thromb. Hemost. 43(2), 2016
PMID: 27556351

Metabolism and secretory function of white adipose tissue: effect of dietary fat.
Oller do Nascimento CM, Ribeiro EB, Oyama LM., An. Acad. Bras. Cienc. 81(3), 2009
PMID: 19722015

A two-step association study identifies CAV2 rs2270188 single nucleotide polymorphism interaction with fat intake in type 2 diabetes risk.
Fisher E, Schreiber S, Joost HG, Boeing H, Doring F., J. Nutr. 141(2), 2010
PMID: 21178094

VLDL activation of plasminogen activator inhibitor-1 (PAI-1) expression: involvement of the VLDL receptor.
Nilsson L, Gafvels M, Musakka L, Ensler K, Strickland DK, Angelin B, Hamsten A, Eriksson P., J. Lipid Res. 40(5), 1999
PMID: 10224160

Adipose tissue secretion of plasminogen activator inhibitor-1 in non-obese and obese individuals.
Eriksson P, Reynisdottir S, Lonnqvist F, Stemme V, Hamsten A, Arner P., Diabetologia 41(1), 1998
PMID: 9498632

AUTHOR UNKNOWN, The Review of Diabetic Studies 7(), 2010

Sex-related differences in the associations between hyperleptinemia, insulin resistance and dysfibrinolysis.
Eriksson MA, Rask E, Johnson O, Carlstrom K, Ahren B, Eliasson M, Boman K, Soderberg S., Blood Coagul. Fibrinolysis 19(7), 2008
PMID: 18832901

Short-term very low-calorie diet in obese females improves the haemostatic balance through the reduction of leptin levels, PAI-1 concentrations and a diminished release of platelet and leukocyte-derived microparticles.
Morel O, Luca F, Grunebaum L, Jesel L, Meyer N, Desprez D, Robert S, Dignat-George F, Toti F, Simon C, Goichot B., Int J Obes (Lond) 35(12), 2011
PMID: 21386797

Role of plasminogen activator inhibitor-1 in senescence and aging.
Eren M, Boe AE, Klyachko EA, Vaughan DE., Semin. Thromb. Hemost. 40(6), 2014
PMID: 25173500

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.
Mavri A, Alessi MC, Bastelica D, Geel-Georgelin O, Fina F, Sentocnik JT, Stegnar M, Juhan-Vague I., Diabetologia 44(11), 2001
PMID: 11719834

Oxidized LDL and lysophosphatidylcholine stimulate plasminogen activator inhibitor-1 expression in vascular smooth muscle cells.
Dichtl W, Stiko A, Eriksson P, Goncalves I, Calara F, Banfi C, Ares MP, Hamsten A, Nilsson J., Arterioscler. Thromb. Vasc. Biol. 19(12), 1999
PMID: 10591684

Plasminogen-mediated activation and release of hepatocyte growth factor from extracellular matrix.
Matsuoka H, Sisson TH, Nishiuma T, Simon RH., Am. J. Respir. Cell Mol. Biol. 35(6), 2006
PMID: 16840775

In vivo stimulation of vascular plasminogen activator inhibitor-1 production by very low-density lipoprotein involves transcription factor binding to a VLDL-responsive element.
Dichtl W, Ares MP, Stollenwerk M, Giachelli CM, Scatena M, Hamsten A, Eriksson P, Nilsson J., Thromb. Haemost. 84(4), 2000
PMID: 11057874

Saturated fatty acid intake can influence increase in plasminogen activator inhibitor-1 in obese adolescents.
Masquio DC, de Piano A, Campos RM, Sanches PL, Corgosinho FC, Carnier J, Oyama LM, do Nascimento CM, de Mello MT, Tufik S, Damaso AR., Horm. Metab. Res. 46(4), 2014
PMID: 24619821

Isocaloric high-fat feeding directs hepatic metabolism to handling of nutrient imbalance promoting liver fat deposition.
Diaz-Rua R, van Schothorst EM, Keijer J, Palou A, Oliver P., Int J Obes (Lond) 40(8), 2016
PMID: 27089994